SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mark j. marvier who wrote (130)10/7/1997 8:41:00 PM
From: Rod Gilchrist   of 337
 
I don't know about too expensive. Up 10% in 16 months doesn't
seem like excessive exhuberance.

The story was pretty good at the time of the IPO (June 96)
and that resulted in an offering price of $11.50 (I bought
some then). The subsequent decline was largely a result of
extremely low volumes due to a lack of a retail following
and the vagaries of the net on a thinly traded stock (I bought
a bunch more then :-).

The story is lots better now than at the $11.50 IPO. Machines
have been delivered (lots of them), they work, and as the two
Richard's point out, the press releases are now emphasizing
higher margin, higher volume test kits, like the HIV test,
as new products.

- Rod

(still working there... still having fun :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News